IP Library Granted Patent US 7,666,429
Granted Patent B2
US 7,666,429 · App. 10/846,341 · Granted Feb 23, 2010

Nucleic acids encoding a house dust mite allergen

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,666,429
App. No.
10/846,341
Granted
Feb 23, 2010
Kind
B2
Abstract

Isolated nucleic acids encoding an allergen of Dermatophagoides pteronyssinus , Der p III, are disclosed. A cDNA encoding a peptide having a Der p III activity and a predicted molecular weight of about 24,985 daltons is also described. The nucleic acids can be used as probes to detect the presence of Der p III nucleic acid in a sample or for the recombinant production of peptides having an activity of Der p III. Peptides having an activity of Der p III can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to house dust mites.

Claims (10)

1. An isolated peptide of a Der p III protein allergen consisting of a portion of the amino acid sequence of SEQ ID NO: 2 at least 30 amino acid residues in length, wherein the peptide is free of all other house dust mite proteins and has at least one of the following features: is capable of stimulating T or B cells specific for a Der p III protein allergen; or includes at least one B cell epitope recognized by a B cell receptor specific for a Der p III protein allergen and wherein the peptide does not comprise the amino acid sequence −29 to 232 or 1-232 of SEQ ID NO: 2.

2. The isolated peptide of claim 1 , which is produced by recombinant expression of a nucleic acid.

3. The isolated peptide of claim 1 , which is produced by chemical synthesis.

4. An isolated peptide of a Der p III protein consisting of a portion of the amino acid sequence of SEQ ID NO: 2 at least 30 amino acid residues in length, wherein the peptide is free of all other house dust mite proteins and wherein the peptide does not comprise the amino acid sequence −29 to 232 or 1-232 of SEQ ID NO: 2.

5. The isolated peptide of claim 4 , consisting of a portion of the amino acid sequence of SEQ ID NO.: 2 at least 60 amino acid residues in length.

6. The isolated peptide of claim 4 , consisting of a portion of the amino acid sequence of SEQ ID NO.: 2 at least 80 amino acid residues in length.

7. The isolated peptide of claim 4 , consisting of a portion of the amino acid sequence of SEQ ID NO.: 2 at least 100 amino acid residues in length.

8. The isolated peptide of claim 1 , consisting of a portion of the amino acid sequence of SEQ ID NO.: 2 at least 60 amino acid residues in length.

9. The isolated peptide of claim 1 , consisting of a portion of the amino acid sequence of SEQ ID NO.: 2 at least 80 amino acid residues in length.

10. The isolated peptide of claim 1 , consisting of a portion of the amino acid sequence of SEQ ID NO.: 2 at least 100 amino acid residues in length.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2006
From: HESKA CORPORATION
To: MERCK PATENT GMBH
Reel/Frame 018654/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2005
From: IMMULOGIC PHARMACEUTICAL CORPORATION
To: HESKA CORPORATION
Reel/Frame 016301/0762 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2005
From: IMMULOGIC PHARMACEUTICAL CORPORATION
To: HESKA CORPORATION
Reel/Frame 016153/0837 →